Drug-induced hyperuricaemia and gout

被引:235
作者
Ben Salem, C. [1 ]
Slim, Raoudha [1 ]
Fathallah, Neila [1 ]
Hmouda, Houssem [2 ]
机构
[1] Fac Med Sousse, Dept Pharmacovigilance, Ave Mohamed Karoui, Sousse 4002, Tunisia
[2] Sahloul Univ Hosp, Med Intens Care Unit, Sousse, Tunisia
关键词
hyperuricaemia; gout; drug-induced; uric acid; diuretics; organic anion transporters; prevention; management; SERUM URIC-ACID; TUMOR LYSIS SYNDROME; PYRAZINAMIDE-INDUCED HYPERURICEMIA; ETHAMBUTOL-INDUCED HYPERURICEMIA; RENAL-TRANSPLANT PATIENTS; URATE EFFLUX TRANSPORTER; NICOTINIC-ACID; INCIDENT GOUT; HYPERTENSIVE PATIENTS; LACTATE INFUSION;
D O I
10.1093/rheumatology/kew293
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Hyperuricaemia is a common clinical condition that can be defined as a serum uric acid level >6.8 mg/dl (404 mu mol/l). Gout, a recognized complication of hyperuricaemia, is the most common inflammatory arthritis in adults. Drug-induced hyperuricaemia and gout present an emergent and increasingly prevalent problem in clinical practice. Diuretics are one of the most important causes of secondary hyperuricaemia. Drugs raise serum uric acid level by an increase of uric acid reabsorption and/or decrease in uric acid secretion. Several drugs may also increase uric acid production. In this review, drugs leading to hyperuricaemia are summarized with regard to their mechanism of action and clinical significance. Increased awareness of drugs that can induce hyperuricaemia and gout, and monitoring and prevention are key elements for reducing the morbidity related to drug-induced hyperuricaemia and gout.
引用
收藏
页码:679 / 688
页数:10
相关论文
共 95 条
[1]
BAETHGE BA, 1993, J RHEUMATOL, V20, P718
[2]
Identification of a new urate and high affinity nicotinate transporter, hOAT10 (SLC22A13) [J].
Bahn, Andrew ;
Hagos, Yohannes ;
Reuter, Stefan ;
Balen, Daniela ;
Brzica, Hrvoje ;
Krick, Wolfgang ;
Burckhardt, Birgitta C. ;
Sabolic, Ivan ;
Burckhardt, Gerhard .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (24) :16332-16341
[3]
Effects of cyclosporine and tacrolimus on maintenance therapy after renal transplantation [J].
Balal, M ;
Paydas, S ;
Sertdemir, Y ;
Karayaylali, I ;
Seyrek, N .
ADVANCES IN THERAPY, 2004, 21 (03) :186-194
[4]
Lack of gene-diuretic interactions on the risk of incident gout: the Nurses' Health Study and Health Professionals Follow-up Study [J].
Bao, Ying ;
Curhan, Gary ;
Merriman, Tony ;
Plenge, Robert ;
Kraft, Peter ;
Choi, Hyon K. .
ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (07) :1394-1398
[5]
BIERER DW, 1982, J PHARMACOL EXP THER, V223, P55
[6]
A review of tumour lysis syndrome with targeted therapies and the role of rasburicase [J].
Bose, P. ;
Qubaiah, O. .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2011, 36 (03) :299-326
[7]
Use of Diuretics and Risk of Incident Gout A Population-Based Case-Control Study [J].
Bruderer, Saskia ;
Bodmer, Michael ;
Jick, Susan S. ;
Meier, Christoph R. .
ARTHRITIS & RHEUMATOLOGY, 2014, 66 (01) :185-196
[8]
Metabolic consequences of a sorbitol overdose during neurosurgery [J].
Buijs, EJ ;
vanZuylen, HJ .
JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY, 1997, 9 (01) :17-20
[9]
HYPERURICEMIA AND GOUT AMONG HEART-TRANSPLANT RECIPIENTS RECEIVING CYCLOSPORINE [J].
BURACK, DA ;
GRIFFITH, BP ;
THOMPSON, ME ;
KAHL, LE .
AMERICAN JOURNAL OF MEDICINE, 1992, 92 (02) :141-146
[10]
BURCH RE, 1968, P SOC EXP BIOL MED, V127, P17